nodes	percent_of_prediction	percent_of_DWPC	metapath
Streptozocin—CYP1A1—Clobetasol propionate—psoriasis	0.221	0.284	CbGbCtD
Streptozocin—CYP1A1—Methoxsalen—psoriasis	0.116	0.149	CbGbCtD
Streptozocin—CYP1A2—Clobetasol propionate—psoriasis	0.0988	0.127	CbGbCtD
Streptozocin—CYP1A1—Cholecalciferol—psoriasis	0.077	0.0988	CbGbCtD
Streptozocin—CYP1A2—Methoxsalen—psoriasis	0.0519	0.0666	CbGbCtD
Streptozocin—CYP1A1—Dexamethasone—psoriasis	0.0333	0.0427	CbGbCtD
Streptozocin—ABCB1—Mycophenolate mofetil—psoriasis	0.0261	0.0335	CbGbCtD
Streptozocin—CYP2E1—Dexamethasone—psoriasis	0.0257	0.033	CbGbCtD
Streptozocin—ABCB1—Betamethasone—psoriasis	0.0224	0.0287	CbGbCtD
Streptozocin—ABCB1—Prednisolone—psoriasis	0.0221	0.0283	CbGbCtD
Streptozocin—ABCB1—Hydrocortisone—psoriasis	0.0209	0.0268	CbGbCtD
Streptozocin—ABCB1—Prednisone—psoriasis	0.0208	0.0267	CbGbCtD
Streptozocin—ABCB1—Cyclosporine—psoriasis	0.0198	0.0254	CbGbCtD
Streptozocin—Ketonuria—Acitretin—psoriasis	0.016	0.0861	CcSEcCtD
Streptozocin—ABCB1—Dexamethasone—psoriasis	0.013	0.0167	CbGbCtD
Streptozocin—ABCB1—Methotrexate—psoriasis	0.0105	0.0134	CbGbCtD
Streptozocin—Hyperchloraemia—Mycophenolate mofetil—psoriasis	0.00748	0.0401	CcSEcCtD
Streptozocin—Renal failure chronic—Calcitriol—psoriasis	0.00631	0.0339	CcSEcCtD
Streptozocin—Glucosamine—IFNG—psoriasis	0.0055	0.705	CrCbGaD
Streptozocin—Burning sensation—Tazarotene—psoriasis	0.00455	0.0244	CcSEcCtD
Streptozocin—Glycosuria—Clobetasol propionate—psoriasis	0.00331	0.0177	CcSEcCtD
Streptozocin—Inflammation—Tazarotene—psoriasis	0.00326	0.0175	CcSEcCtD
Streptozocin—Tenderness—Clobetasol propionate—psoriasis	0.00307	0.0165	CcSEcCtD
Streptozocin—Glycosuria—Fluocinonide—psoriasis	0.00298	0.016	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Prednisolone—psoriasis	0.00272	0.0146	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Hydrocortisone—psoriasis	0.00265	0.0142	CcSEcCtD
Streptozocin—Myelosuppression—Hydroxyurea—psoriasis	0.00253	0.0136	CcSEcCtD
Streptozocin—Nephrotoxicity—Cyclosporine—psoriasis	0.00253	0.0136	CcSEcCtD
Streptozocin—Febrile neutropenia—Acitretin—psoriasis	0.00251	0.0135	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Triamcinolone—psoriasis	0.0025	0.0134	CcSEcCtD
Streptozocin—Glucosamine—TNF—psoriasis	0.0023	0.295	CrCbGaD
Streptozocin—Glucose tolerance impaired—Betamethasone—psoriasis	0.00227	0.0122	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Dexamethasone—psoriasis	0.00227	0.0122	CcSEcCtD
Streptozocin—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00222	0.0833	CbGpPWpGaD
Streptozocin—Tenderness—Methoxsalen—psoriasis	0.00219	0.0117	CcSEcCtD
Streptozocin—Neoplasm malignant—Calcitriol—psoriasis	0.00199	0.0107	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Prednisone—psoriasis	0.00197	0.0106	CcSEcCtD
Streptozocin—Febrile neutropenia—Hydroxyurea—psoriasis	0.00197	0.0106	CcSEcCtD
Streptozocin—Inflammation—Methoxsalen—psoriasis	0.00197	0.0105	CcSEcCtD
Streptozocin—Erythema—Calcipotriol—psoriasis	0.00187	0.0101	CcSEcCtD
Streptozocin—Glycosuria—Acitretin—psoriasis	0.00187	0.01	CcSEcCtD
Streptozocin—Proteinuria—Acitretin—psoriasis	0.00172	0.00923	CcSEcCtD
Streptozocin—Hypophosphataemia—Mycophenolic acid—psoriasis	0.00171	0.00918	CcSEcCtD
Streptozocin—Protein urine present—Acitretin—psoriasis	0.0017	0.00911	CcSEcCtD
Streptozocin—Blood urea increased—Calcitriol—psoriasis	0.0016	0.00861	CcSEcCtD
Streptozocin—Hepatotoxicity—Hydroxyurea—psoriasis	0.00154	0.00825	CcSEcCtD
Streptozocin—Azotaemia—Cyclosporine—psoriasis	0.00151	0.0081	CcSEcCtD
Streptozocin—Azotaemia—Mycophenolate mofetil—psoriasis	0.00147	0.0079	CcSEcCtD
Streptozocin—Nephropathy toxic—Cyclosporine—psoriasis	0.0014	0.00752	CcSEcCtD
Streptozocin—Erythema—Tazarotene—psoriasis	0.00138	0.00741	CcSEcCtD
Streptozocin—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00138	0.0516	CbGpPWpGaD
Streptozocin—Tenderness—Hydroxyurea—psoriasis	0.00136	0.0073	CcSEcCtD
Streptozocin—Hypophosphataemia—Mycophenolate mofetil—psoriasis	0.00135	0.00725	CcSEcCtD
Streptozocin—Pain—Calcipotriol—psoriasis	0.00131	0.00702	CcSEcCtD
Streptozocin—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.0013	0.0487	CbGpPWpGaD
Streptozocin—Anuria—Methotrexate—psoriasis	0.00127	0.00683	CcSEcCtD
Streptozocin—Hepatic enzyme increased—Hydroxyurea—psoriasis	0.00126	0.00673	CcSEcCtD
Streptozocin—SLC2A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00121	0.0455	CbGpPWpGaD
Streptozocin—Haematocrit decreased—Methotrexate—psoriasis	0.00119	0.0064	CcSEcCtD
Streptozocin—Erythema—Clobetasol propionate—psoriasis	0.00117	0.00628	CcSEcCtD
Streptozocin—Neoplasm malignant—Mycophenolic acid—psoriasis	0.00116	0.00625	CcSEcCtD
Streptozocin—Burning sensation—Cyclosporine—psoriasis	0.00116	0.00621	CcSEcCtD
Streptozocin—Oedema—Tazarotene—psoriasis	0.00113	0.00605	CcSEcCtD
Streptozocin—Hypoglycaemia—Fluocinolone Acetonide—psoriasis	0.00112	0.00602	CcSEcCtD
Streptozocin—Blood urea increased—Hydroxyurea—psoriasis	0.00112	0.00601	CcSEcCtD
Streptozocin—Hypocalcaemia—Mycophenolic acid—psoriasis	0.00109	0.00583	CcSEcCtD
Streptozocin—Erythema—Fluocinonide—psoriasis	0.00106	0.00567	CcSEcCtD
Streptozocin—Hepatotoxicity—Cyclosporine—psoriasis	0.00104	0.00559	CcSEcCtD
Streptozocin—Pain—Tazarotene—psoriasis	0.000964	0.00517	CcSEcCtD
Streptozocin—Neoplasm malignant—Cyclosporine—psoriasis	0.000942	0.00505	CcSEcCtD
Streptozocin—Blood urea increased—Mycophenolic acid—psoriasis	0.000939	0.00504	CcSEcCtD
Streptozocin—Necrosis—Hydrocortisone—psoriasis	0.000911	0.00489	CcSEcCtD
Streptozocin—Pancytopenia—Acitretin—psoriasis	0.000901	0.00483	CcSEcCtD
Streptozocin—Febrile neutropenia—Prednisone—psoriasis	0.000884	0.00474	CcSEcCtD
Streptozocin—Glycosuria—Hydrocortisone—psoriasis	0.000882	0.00473	CcSEcCtD
Streptozocin—Hypocalcaemia—Mycophenolate mofetil—psoriasis	0.000857	0.0046	CcSEcCtD
Streptozocin—SLC2A2—Type II diabetes mellitus—TNF—psoriasis	0.000839	0.0315	CbGpPWpGaD
Streptozocin—SLC2A2—NRF2 pathway—TGFA—psoriasis	0.000835	0.0313	CbGpPWpGaD
Streptozocin—Azotaemia—Methotrexate—psoriasis	0.000834	0.00448	CcSEcCtD
Streptozocin—Erythema—Methoxsalen—psoriasis	0.000834	0.00447	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—IL22—psoriasis	0.000832	0.0312	CbGpPWpGaD
Streptozocin—Glycosuria—Triamcinolone—psoriasis	0.000831	0.00446	CcSEcCtD
Streptozocin—Hepatic enzyme increased—Mycophenolate mofetil—psoriasis	0.00083	0.00445	CcSEcCtD
Streptozocin—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000827	0.031	CbGpPWpGaD
Streptozocin—Pain—Clobetasol propionate—psoriasis	0.000817	0.00439	CcSEcCtD
Streptozocin—Necrosis—Betamethasone—psoriasis	0.000778	0.00418	CcSEcCtD
Streptozocin—Necrosis—Dexamethasone—psoriasis	0.000778	0.00418	CcSEcCtD
Streptozocin—Blood urea increased—Cyclosporine—psoriasis	0.000759	0.00407	CcSEcCtD
Streptozocin—Glycosuria—Betamethasone—psoriasis	0.000754	0.00405	CcSEcCtD
Streptozocin—Glycosuria—Dexamethasone—psoriasis	0.000754	0.00405	CcSEcCtD
Streptozocin—Pain—Beclomethasone—psoriasis	0.000744	0.00399	CcSEcCtD
Streptozocin—Erythema—Calcitriol—psoriasis	0.000743	0.00399	CcSEcCtD
Streptozocin—Blood urea increased—Mycophenolate mofetil—psoriasis	0.000741	0.00398	CcSEcCtD
Streptozocin—Hypoglycaemia—Mycophenolic acid—psoriasis	0.00074	0.00397	CcSEcCtD
Streptozocin—Febrile neutropenia—Methotrexate—psoriasis	0.000739	0.00396	CcSEcCtD
Streptozocin—Pain—Fluocinonide—psoriasis	0.000737	0.00396	CcSEcCtD
Streptozocin—Inflammation—Hydrocortisone—psoriasis	0.000737	0.00395	CcSEcCtD
Streptozocin—Pancytopenia—Hydroxyurea—psoriasis	0.000707	0.0038	CcSEcCtD
Streptozocin—Extravasation—Dexamethasone—psoriasis	0.0007	0.00376	CcSEcCtD
Streptozocin—Extravasation—Betamethasone—psoriasis	0.0007	0.00376	CcSEcCtD
Streptozocin—Neutropenia—Hydroxyurea—psoriasis	0.000696	0.00374	CcSEcCtD
Streptozocin—Oedema—Methoxsalen—psoriasis	0.00068	0.00365	CcSEcCtD
Streptozocin—Necrosis—Prednisone—psoriasis	0.000678	0.00364	CcSEcCtD
Streptozocin—Erythema—Acitretin—psoriasis	0.000661	0.00355	CcSEcCtD
Streptozocin—Erythema—Fluocinolone Acetonide—psoriasis	0.000659	0.00354	CcSEcCtD
Streptozocin—Hypokalaemia—Mycophenolic acid—psoriasis	0.000657	0.00352	CcSEcCtD
Streptozocin—Glycosuria—Prednisone—psoriasis	0.000657	0.00352	CcSEcCtD
Streptozocin—Burning sensation—Methotrexate—psoriasis	0.00064	0.00343	CcSEcCtD
Streptozocin—Hypoglycaemia—Cyclosporine—psoriasis	0.000598	0.00321	CcSEcCtD
Streptozocin—Lethargy—Cyclosporine—psoriasis	0.000596	0.0032	CcSEcCtD
Streptozocin—Pancytopenia—Mycophenolic acid—psoriasis	0.000592	0.00318	CcSEcCtD
Streptozocin—Hypoglycaemia—Mycophenolate mofetil—psoriasis	0.000584	0.00313	CcSEcCtD
Streptozocin—Neutropenia—Mycophenolic acid—psoriasis	0.000583	0.00313	CcSEcCtD
Streptozocin—Hepatotoxicity—Methotrexate—psoriasis	0.000576	0.00309	CcSEcCtD
Streptozocin—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000571	0.0214	CbGpPWpGaD
Streptozocin—Necrosis—Methotrexate—psoriasis	0.000566	0.00304	CcSEcCtD
Streptozocin—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000564	0.0212	CbGpPWpGaD
Streptozocin—Feeling abnormal—Methoxsalen—psoriasis	0.000561	0.00301	CcSEcCtD
Streptozocin—SLC2A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000551	0.0207	CbGpPWpGaD
Streptozocin—Oedema—Acitretin—psoriasis	0.000539	0.00289	CcSEcCtD
Streptozocin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000539	0.0202	CbGpPWpGaD
Streptozocin—Oedema—Fluocinolone Acetonide—psoriasis	0.000538	0.00289	CcSEcCtD
Streptozocin—Body temperature increased—Methoxsalen—psoriasis	0.000538	0.00289	CcSEcCtD
Streptozocin—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000532	0.0199	CbGpPWpGaD
Streptozocin—Lethargy—Hydrocortisone—psoriasis	0.00053	0.00284	CcSEcCtD
Streptozocin—Erythema—Hydroxyurea—psoriasis	0.000519	0.00278	CcSEcCtD
Streptozocin—Pain—Calcitriol—psoriasis	0.000519	0.00278	CcSEcCtD
Streptozocin—Hypokalaemia—Mycophenolate mofetil—psoriasis	0.000518	0.00278	CcSEcCtD
Streptozocin—Nausea—Beclomethasone—psoriasis	0.000517	0.00277	CcSEcCtD
Streptozocin—Extravasation—Methotrexate—psoriasis	0.000509	0.00273	CcSEcCtD
Streptozocin—Proteinuria—Methotrexate—psoriasis	0.000506	0.00271	CcSEcCtD
Streptozocin—Protein urine present—Methotrexate—psoriasis	0.000499	0.00268	CcSEcCtD
Streptozocin—Anaemia—Hydroxyurea—psoriasis	0.00048	0.00257	CcSEcCtD
Streptozocin—Body temperature increased—Calcitriol—psoriasis	0.000479	0.00257	CcSEcCtD
Streptozocin—Hypokalaemia—Hydrocortisone—psoriasis	0.000472	0.00253	CcSEcCtD
Streptozocin—Hepatic enzyme increased—Methotrexate—psoriasis	0.00047	0.00252	CcSEcCtD
Streptozocin—Pancytopenia—Mycophenolate mofetil—psoriasis	0.000468	0.00251	CcSEcCtD
Streptozocin—Leukopenia—Hydroxyurea—psoriasis	0.000465	0.00249	CcSEcCtD
Streptozocin—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000463	0.0174	CbGpPWpGaD
Streptozocin—Pain—Acitretin—psoriasis	0.000461	0.00248	CcSEcCtD
Streptozocin—Neutropenia—Mycophenolate mofetil—psoriasis	0.00046	0.00247	CcSEcCtD
Streptozocin—Pain—Fluocinolone Acetonide—psoriasis	0.00046	0.00247	CcSEcCtD
Streptozocin—Inflammation—Methotrexate—psoriasis	0.000458	0.00246	CcSEcCtD
Streptozocin—Lethargy—Dexamethasone—psoriasis	0.000452	0.00243	CcSEcCtD
Streptozocin—Lethargy—Betamethasone—psoriasis	0.000452	0.00243	CcSEcCtD
Streptozocin—Feeling abnormal—Acitretin—psoriasis	0.000445	0.00239	CcSEcCtD
Streptozocin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000437	0.0164	CbGpPWpGaD
Streptozocin—Body temperature increased—Acitretin—psoriasis	0.000426	0.00229	CcSEcCtD
Streptozocin—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000425	0.00228	CcSEcCtD
Streptozocin—Oedema—Hydroxyurea—psoriasis	0.000424	0.00227	CcSEcCtD
Streptozocin—Diarrhoea—Calcitriol—psoriasis	0.000415	0.00223	CcSEcCtD
Streptozocin—Thrombocytopenia—Hydroxyurea—psoriasis	0.000415	0.00223	CcSEcCtD
Streptozocin—Nausea—Methoxsalen—psoriasis	0.000404	0.00217	CcSEcCtD
Streptozocin—Hypokalaemia—Betamethasone—psoriasis	0.000403	0.00217	CcSEcCtD
Streptozocin—Hypokalaemia—Dexamethasone—psoriasis	0.000403	0.00217	CcSEcCtD
Streptozocin—Anaemia—Mycophenolic acid—psoriasis	0.000402	0.00216	CcSEcCtD
Streptozocin—Lethargy—Prednisone—psoriasis	0.000394	0.00211	CcSEcCtD
Streptozocin—Leukopenia—Mycophenolic acid—psoriasis	0.000389	0.00209	CcSEcCtD
Streptozocin—Vomiting—Calcitriol—psoriasis	0.000386	0.00207	CcSEcCtD
Streptozocin—Diarrhoea—Acitretin—psoriasis	0.000369	0.00198	CcSEcCtD
Streptozocin—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000368	0.00198	CcSEcCtD
Streptozocin—Pain—Hydroxyurea—psoriasis	0.000362	0.00194	CcSEcCtD
Streptozocin—Nausea—Calcitriol—psoriasis	0.00036	0.00193	CcSEcCtD
Streptozocin—Confusional state—Mycophenolic acid—psoriasis	0.000358	0.00192	CcSEcCtD
Streptozocin—Oedema—Mycophenolic acid—psoriasis	0.000355	0.0019	CcSEcCtD
Streptozocin—Hypokalaemia—Prednisone—psoriasis	0.000351	0.00189	CcSEcCtD
Streptozocin—Feeling abnormal—Hydroxyurea—psoriasis	0.000349	0.00187	CcSEcCtD
Streptozocin—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000347	0.00186	CcSEcCtD
Streptozocin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000344	0.0129	CbGpPWpGaD
Streptozocin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000343	0.0129	CbGpPWpGaD
Streptozocin—Vomiting—Acitretin—psoriasis	0.000343	0.00184	CcSEcCtD
Streptozocin—Vomiting—Fluocinolone Acetonide—psoriasis	0.000342	0.00184	CcSEcCtD
Streptozocin—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000339	0.0127	CbGpPWpGaD
Streptozocin—Body temperature increased—Hydroxyurea—psoriasis	0.000335	0.0018	CcSEcCtD
Streptozocin—Lethargy—Methotrexate—psoriasis	0.000329	0.00177	CcSEcCtD
Streptozocin—Anaemia—Cyclosporine—psoriasis	0.000325	0.00174	CcSEcCtD
Streptozocin—Nausea—Acitretin—psoriasis	0.00032	0.00172	CcSEcCtD
Streptozocin—Erythema—Prednisolone—psoriasis	0.00032	0.00172	CcSEcCtD
Streptozocin—Nausea—Fluocinolone Acetonide—psoriasis	0.00032	0.00171	CcSEcCtD
Streptozocin—Anaemia—Mycophenolate mofetil—psoriasis	0.000317	0.0017	CcSEcCtD
Streptozocin—Leukopenia—Cyclosporine—psoriasis	0.000315	0.00169	CcSEcCtD
Streptozocin—SLC2A2—Developmental Biology—CARM1—psoriasis	0.000315	0.0118	CbGpPWpGaD
Streptozocin—Erythema—Hydrocortisone—psoriasis	0.000313	0.00168	CcSEcCtD
Streptozocin—Neutropenia—Prednisone—psoriasis	0.000312	0.00167	CcSEcCtD
Streptozocin—Leukopenia—Mycophenolate mofetil—psoriasis	0.000307	0.00165	CcSEcCtD
Streptozocin—Pain—Mycophenolic acid—psoriasis	0.000303	0.00163	CcSEcCtD
Streptozocin—SLC2A2—Metabolism—NDUFA5—psoriasis	0.000301	0.0113	CbGpPWpGaD
Streptozocin—Erythema—Triamcinolone—psoriasis	0.000294	0.00158	CcSEcCtD
Streptozocin—Feeling abnormal—Mycophenolic acid—psoriasis	0.000292	0.00157	CcSEcCtD
Streptozocin—Diarrhoea—Hydroxyurea—psoriasis	0.00029	0.00156	CcSEcCtD
Streptozocin—Confusional state—Cyclosporine—psoriasis	0.000289	0.00155	CcSEcCtD
Streptozocin—Oedema—Cyclosporine—psoriasis	0.000287	0.00154	CcSEcCtD
Streptozocin—Confusional state—Mycophenolate mofetil—psoriasis	0.000282	0.00151	CcSEcCtD
Streptozocin—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000282	0.0106	CbGpPWpGaD
Streptozocin—Thrombocytopenia—Cyclosporine—psoriasis	0.000281	0.00151	CcSEcCtD
Streptozocin—Body temperature increased—Mycophenolic acid—psoriasis	0.00028	0.0015	CcSEcCtD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—CP—psoriasis	0.00028	0.0105	CbGpPWpGaD
Streptozocin—Oedema—Mycophenolate mofetil—psoriasis	0.00028	0.0015	CcSEcCtD
Streptozocin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000278	0.0104	CbGpPWpGaD
Streptozocin—Eosinophilia—Methotrexate—psoriasis	0.000276	0.00148	CcSEcCtD
Streptozocin—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000274	0.00147	CcSEcCtD
Streptozocin—Vomiting—Hydroxyurea—psoriasis	0.000269	0.00145	CcSEcCtD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000267	0.01	CbGpPWpGaD
Streptozocin—Erythema—Dexamethasone—psoriasis	0.000267	0.00143	CcSEcCtD
Streptozocin—Erythema—Betamethasone—psoriasis	0.000267	0.00143	CcSEcCtD
Streptozocin—Pancytopenia—Methotrexate—psoriasis	0.000265	0.00142	CcSEcCtD
Streptozocin—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000264	0.00991	CbGpPWpGaD
Streptozocin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000262	0.00985	CbGpPWpGaD
Streptozocin—Oedema—Prednisolone—psoriasis	0.000261	0.0014	CcSEcCtD
Streptozocin—Neutropenia—Methotrexate—psoriasis	0.000261	0.0014	CcSEcCtD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000258	0.0097	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—CYP2S1—psoriasis	0.000256	0.00962	CbGpPWpGaD
Streptozocin—Oedema—Hydrocortisone—psoriasis	0.000255	0.00137	CcSEcCtD
Streptozocin—Nausea—Hydroxyurea—psoriasis	0.000252	0.00135	CcSEcCtD
Streptozocin—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000246	0.00923	CbGpPWpGaD
Streptozocin—Pain—Cyclosporine—psoriasis	0.000245	0.00132	CcSEcCtD
Streptozocin—Diarrhoea—Mycophenolic acid—psoriasis	0.000243	0.0013	CcSEcCtD
Streptozocin—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000243	0.00911	CbGpPWpGaD
Streptozocin—Oedema—Triamcinolone—psoriasis	0.00024	0.00129	CcSEcCtD
Streptozocin—Pain—Mycophenolate mofetil—psoriasis	0.000239	0.00128	CcSEcCtD
Streptozocin—Feeling abnormal—Cyclosporine—psoriasis	0.000236	0.00127	CcSEcCtD
Streptozocin—Erythema—Prednisone—psoriasis	0.000233	0.00125	CcSEcCtD
Streptozocin—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000232	0.0087	CbGpPWpGaD
Streptozocin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000231	0.00124	CcSEcCtD
Streptozocin—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000229	0.00858	CbGpPWpGaD
Streptozocin—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000228	0.00857	CbGpPWpGaD
Streptozocin—Body temperature increased—Cyclosporine—psoriasis	0.000227	0.00122	CcSEcCtD
Streptozocin—Vomiting—Mycophenolic acid—psoriasis	0.000226	0.00121	CcSEcCtD
Streptozocin—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000225	0.00844	CbGpPWpGaD
Streptozocin—Pain—Prednisolone—psoriasis	0.000223	0.0012	CcSEcCtD
Streptozocin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000221	0.00119	CcSEcCtD
Streptozocin—Pain—Hydrocortisone—psoriasis	0.000218	0.00117	CcSEcCtD
Streptozocin—Oedema—Betamethasone—psoriasis	0.000218	0.00117	CcSEcCtD
Streptozocin—Oedema—Dexamethasone—psoriasis	0.000218	0.00117	CcSEcCtD
Streptozocin—Feeling abnormal—Prednisolone—psoriasis	0.000215	0.00115	CcSEcCtD
Streptozocin—Anaemia—Prednisone—psoriasis	0.000215	0.00115	CcSEcCtD
Streptozocin—Thrombocytopenia—Betamethasone—psoriasis	0.000213	0.00114	CcSEcCtD
Streptozocin—Thrombocytopenia—Dexamethasone—psoriasis	0.000213	0.00114	CcSEcCtD
Streptozocin—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000212	0.00797	CbGpPWpGaD
Streptozocin—Nausea—Mycophenolic acid—psoriasis	0.000211	0.00113	CcSEcCtD
Streptozocin—Feeling abnormal—Hydrocortisone—psoriasis	0.00021	0.00113	CcSEcCtD
Streptozocin—Pain—Triamcinolone—psoriasis	0.000205	0.0011	CcSEcCtD
Streptozocin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000204	0.00766	CbGpPWpGaD
Streptozocin—Body temperature increased—Hydrocortisone—psoriasis	0.000202	0.00108	CcSEcCtD
Streptozocin—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.0002	0.00751	CbGpPWpGaD
Streptozocin—Feeling abnormal—Triamcinolone—psoriasis	0.000198	0.00106	CcSEcCtD
Streptozocin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000198	0.00742	CbGpPWpGaD
Streptozocin—Diarrhoea—Cyclosporine—psoriasis	0.000196	0.00105	CcSEcCtD
Streptozocin—Erythema—Methotrexate—psoriasis	0.000194	0.00104	CcSEcCtD
Streptozocin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000192	0.00103	CcSEcCtD
Streptozocin—Body temperature increased—Triamcinolone—psoriasis	0.00019	0.00102	CcSEcCtD
Streptozocin—Oedema—Prednisone—psoriasis	0.00019	0.00102	CcSEcCtD
Streptozocin—Pain—Dexamethasone—psoriasis	0.000186	0.001	CcSEcCtD
Streptozocin—Pain—Betamethasone—psoriasis	0.000186	0.001	CcSEcCtD
Streptozocin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000183	0.00687	CbGpPWpGaD
Streptozocin—Vomiting—Cyclosporine—psoriasis	0.000182	0.000979	CcSEcCtD
Streptozocin—Anaemia—Methotrexate—psoriasis	0.00018	0.000964	CcSEcCtD
Streptozocin—Feeling abnormal—Dexamethasone—psoriasis	0.00018	0.000964	CcSEcCtD
Streptozocin—Feeling abnormal—Betamethasone—psoriasis	0.00018	0.000964	CcSEcCtD
Streptozocin—Vomiting—Mycophenolate mofetil—psoriasis	0.000178	0.000955	CcSEcCtD
Streptozocin—Diarrhoea—Hydrocortisone—psoriasis	0.000175	0.000936	CcSEcCtD
Streptozocin—Leukopenia—Methotrexate—psoriasis	0.000174	0.000933	CcSEcCtD
Streptozocin—Body temperature increased—Dexamethasone—psoriasis	0.000172	0.000924	CcSEcCtD
Streptozocin—Body temperature increased—Betamethasone—psoriasis	0.000172	0.000924	CcSEcCtD
Streptozocin—Nausea—Cyclosporine—psoriasis	0.00017	0.000915	CcSEcCtD
Streptozocin—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000168	0.00632	CbGpPWpGaD
Streptozocin—Nausea—Mycophenolate mofetil—psoriasis	0.000166	0.000892	CcSEcCtD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000165	0.00618	CbGpPWpGaD
Streptozocin—Vomiting—Hydrocortisone—psoriasis	0.000162	0.00087	CcSEcCtD
Streptozocin—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000162	0.00608	CbGpPWpGaD
Streptozocin—Confusional state—Methotrexate—psoriasis	0.00016	0.000858	CcSEcCtD
Streptozocin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000159	0.00595	CbGpPWpGaD
Streptozocin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000158	0.00592	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000158	0.00591	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000157	0.00587	CbGpPWpGaD
Streptozocin—Feeling abnormal—Prednisone—psoriasis	0.000156	0.000839	CcSEcCtD
Streptozocin—Thrombocytopenia—Methotrexate—psoriasis	0.000155	0.000833	CcSEcCtD
Streptozocin—Nausea—Prednisolone—psoriasis	0.000155	0.000832	CcSEcCtD
Streptozocin—Vomiting—Triamcinolone—psoriasis	0.000153	0.000819	CcSEcCtD
Streptozocin—Nausea—Hydrocortisone—psoriasis	0.000151	0.000813	CcSEcCtD
Streptozocin—SLC2A2—Developmental Biology—LEP—psoriasis	0.00015	0.00564	CbGpPWpGaD
Streptozocin—Body temperature increased—Prednisone—psoriasis	0.00015	0.000805	CcSEcCtD
Streptozocin—Diarrhoea—Dexamethasone—psoriasis	0.000149	0.0008	CcSEcCtD
Streptozocin—Diarrhoea—Betamethasone—psoriasis	0.000149	0.0008	CcSEcCtD
Streptozocin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000148	0.00555	CbGpPWpGaD
Streptozocin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000146	0.00547	CbGpPWpGaD
Streptozocin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000146	0.00546	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000144	0.00541	CbGpPWpGaD
Streptozocin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000143	0.00538	CbGpPWpGaD
Streptozocin—Nausea—Triamcinolone—psoriasis	0.000143	0.000765	CcSEcCtD
Streptozocin—Vomiting—Betamethasone—psoriasis	0.000139	0.000743	CcSEcCtD
Streptozocin—Vomiting—Dexamethasone—psoriasis	0.000139	0.000743	CcSEcCtD
Streptozocin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000138	0.00517	CbGpPWpGaD
Streptozocin—Pain—Methotrexate—psoriasis	0.000136	0.000728	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000134	0.00503	CbGpPWpGaD
Streptozocin—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000134	0.00502	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—PPARG—psoriasis	0.000131	0.00492	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000131	0.00491	CbGpPWpGaD
Streptozocin—Feeling abnormal—Methotrexate—psoriasis	0.000131	0.000701	CcSEcCtD
Streptozocin—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.00013	0.00488	CbGpPWpGaD
Streptozocin—Diarrhoea—Prednisone—psoriasis	0.00013	0.000697	CcSEcCtD
Streptozocin—Nausea—Dexamethasone—psoriasis	0.000129	0.000695	CcSEcCtD
Streptozocin—Nausea—Betamethasone—psoriasis	0.000129	0.000695	CcSEcCtD
Streptozocin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000128	0.00479	CbGpPWpGaD
Streptozocin—Body temperature increased—Methotrexate—psoriasis	0.000125	0.000673	CcSEcCtD
Streptozocin—SLC2A2—Metabolism—CARM1—psoriasis	0.000125	0.0047	CbGpPWpGaD
Streptozocin—Vomiting—Prednisone—psoriasis	0.000121	0.000647	CcSEcCtD
Streptozocin—SLC2A2—Developmental Biology—TYK2—psoriasis	0.000115	0.00431	CbGpPWpGaD
Streptozocin—Nausea—Prednisone—psoriasis	0.000113	0.000605	CcSEcCtD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000111	0.00417	CbGpPWpGaD
Streptozocin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00011	0.00413	CbGpPWpGaD
Streptozocin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000109	0.0041	CbGpPWpGaD
Streptozocin—Diarrhoea—Methotrexate—psoriasis	0.000109	0.000582	CcSEcCtD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000108	0.00406	CbGpPWpGaD
Streptozocin—Vomiting—Methotrexate—psoriasis	0.000101	0.000541	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—IL10—psoriasis	9.79e-05	0.00367	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	9.61e-05	0.0036	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL4—psoriasis	9.53e-05	0.00357	CbGpPWpGaD
Streptozocin—Nausea—Methotrexate—psoriasis	9.42e-05	0.000505	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—HLA-B—psoriasis	9.32e-05	0.0035	CbGpPWpGaD
Streptozocin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	9.31e-05	0.00349	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.25e-05	0.00347	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—NFKB1—psoriasis	8.94e-05	0.00336	CbGpPWpGaD
Streptozocin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	8.67e-05	0.00325	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-A—psoriasis	8.63e-05	0.00324	CbGpPWpGaD
Streptozocin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	8.53e-05	0.0032	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	8.39e-05	0.00315	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—VEGFA—psoriasis	8.12e-05	0.00305	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—STAT3—psoriasis	8.04e-05	0.00302	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	7.89e-05	0.00296	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—CAT—psoriasis	7.7e-05	0.00289	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—HLA-A—psoriasis	7.65e-05	0.00287	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.19e-05	0.0027	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.19e-05	0.0027	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—APOE—psoriasis	7.14e-05	0.00268	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.09e-05	0.00266	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—TNF—psoriasis	6.96e-05	0.00261	CbGpPWpGaD
Streptozocin—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	6.74e-05	0.00253	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—NOS2—psoriasis	6.66e-05	0.0025	CbGpPWpGaD
Streptozocin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	6.6e-05	0.00248	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.13e-05	0.0023	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—APOE—psoriasis	5.98e-05	0.00224	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.9e-05	0.00221	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IFNG—psoriasis	5.76e-05	0.00216	CbGpPWpGaD
Streptozocin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.75e-05	0.00216	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—IL6—psoriasis	5.61e-05	0.00211	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—TYK2—psoriasis	5.45e-05	0.00205	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CXCL8—psoriasis	5.36e-05	0.00201	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.35e-05	0.00201	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—PPARG—psoriasis	5.21e-05	0.00196	CbGpPWpGaD
Streptozocin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.02e-05	0.00188	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—NDUFA5—psoriasis	4.95e-05	0.00186	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—CD4—psoriasis	4.93e-05	0.00185	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—NDUFA5—psoriasis	4.67e-05	0.00175	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.59e-05	0.00172	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.59e-05	0.00172	CbGpPWpGaD
Streptozocin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	4.55e-05	0.00171	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.41e-05	0.00165	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.35e-05	0.00163	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—VEGFA—psoriasis	4.35e-05	0.00163	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—CYP2S1—psoriasis	4.21e-05	0.00158	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—CYP2S1—psoriasis	3.97e-05	0.00149	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—STAT3—psoriasis	3.82e-05	0.00143	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—TNF—psoriasis	3.73e-05	0.0014	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—NDUFA5—psoriasis	3.73e-05	0.0014	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.71e-05	0.00139	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.46e-05	0.0013	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.3e-05	0.00124	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—CYP2S1—psoriasis	3.17e-05	0.00119	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—NDUFA5—psoriasis	2.97e-05	0.00112	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.77e-05	0.00104	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—IL6—psoriasis	2.67e-05	0.001	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—CYP2S1—psoriasis	2.53e-05	0.000949	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.46e-05	0.000922	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.36e-05	0.000887	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.15e-05	0.000805	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.08e-05	0.00078	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—CARM1—psoriasis	2.05e-05	0.000771	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—CARM1—psoriasis	1.94e-05	0.000727	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.84e-05	0.00069	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.81e-05	0.000679	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.62e-05	0.000609	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—CARM1—psoriasis	1.55e-05	0.000581	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.33e-05	0.000497	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—CAT—psoriasis	1.26e-05	0.000474	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—CARM1—psoriasis	1.24e-05	0.000464	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—CAT—psoriasis	1.19e-05	0.000447	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.15e-05	0.000433	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—APOE—psoriasis	9.82e-06	0.000368	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—CAT—psoriasis	9.52e-06	0.000357	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—APOE—psoriasis	9.26e-06	0.000347	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—PPARG—psoriasis	8.55e-06	0.000321	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—PPARG—psoriasis	8.07e-06	0.000303	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—CAT—psoriasis	7.6e-06	0.000285	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—APOE—psoriasis	7.4e-06	0.000277	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—PPARG—psoriasis	6.44e-06	0.000242	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—APOE—psoriasis	5.9e-06	0.000222	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—PPARG—psoriasis	5.14e-06	0.000193	CbGpPWpGaD
